IOBT - IO Biotech, Inc.

QQQ $ 608.45 $ 0.46 (0.08 %)

DIA $ 471.65 $ -2.94 (-0.62 %)

SPY $ 671.62 $ -0.11 (-0.02 %)

TLT $ 88.93 $ -0.51 (-0.57 %)

GLD $ 375.82 $ -6.91 (-1.8 %)

Previous Close

$ 0.8276

Open

$ 0.78

Bid

$ 0.82 x 1,500

Ask

$ 0.83 x 59

Day's Range

$ 0.79 - $ 0.83

52 Week Range

$ 0.32 - $ 2.79

Volume

414,842

Average Volume

Market Cap

59.54M

Beta (5Y Monthly)

$ 1.15

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-14-2025	09-30-2025	10-Q
2	08-14-2025	06-30-2025	10-Q
3	05-14-2025	03-31-2025	10-Q
4	03-31-2025	12-31-2024	10-K
5	11-12-2024	09-30-2024	10-Q
6	08-13-2024	06-30-2024	10-Q
7	05-14-2024	03-31-2024	10-Q
8	03-05-2024	12-31-2023	10-K
9	11-13-2023	09-30-2023	10-Q
10	08-11-2023	06-30-2023	10-Q
11	05-11-2023	03-31-2023	10-Q
12	03-14-2023	12-31-2022	10-K
13	11-09-2022	09-30-2022	10-Q
14	08-11-2022	06-30-2022	10-Q
15	05-16-2022	03-31-2022	10-Q
16	03-31-2022	12-31-2021	10-K
17	12-17-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

IO Biotech Q3 EPS $(0.13) Beats $(0.34) Es...
11/14/2025 13:11:44

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.34) by...

IO Biotech To Present New Pre-Clinical Dat...
11/07/2025 14:06:06

Pre-clinical data for IO Biotech's next T-win vaccine candidate, IO112 targeting arginase 1, demonstrates anti-tumor activi...

12 Health Care Stocks Moving In Thursday's...
10/23/2025 17:07:13

Piper Sandler Maintains Overweight on IO B...
10/22/2025 15:26:34

Piper Sandler analyst Allison Bratzel maintains IO Biotech (NASDAQ:IOBT) with a Overweight and lowers the price target from ...

12 Health Care Stocks Moving In Monday's P...
10/20/2025 12:08:17

IO Biotech Phase 3: Cylembio Plus KEYTRUDA...
10/20/2025 06:48:42

Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0...

12 Health Care Stocks Moving In Thursday's...
10/02/2025 17:06:31

TD Cowen Downgrades IO Biotech to Hold
09/30/2025 15:15:19

TD Cowen analyst Yaron Werber downgrades IO Biotech (NASDAQ:IOBT) from Buy to Hold.

crude-oil-falls-sharply-carnival-posts-upbeat-earnings

Crude Oil Falls Sharply; Carnival Posts Up...
09/29/2025 17:14:55

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Monday. The Dow traded do...

12 Health Care Stocks Moving In Monday's I...
09/29/2025 17:06:50

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

HC Wainwright & Co. Downgrades IO Biotech ...
09/29/2025 16:24:17

HC Wainwright & Co. analyst Emily Bodnar downgrades IO Biotech (NASDAQ: IOBT) from Buy to Neutral.

nasdaq-jumps-150-points-us-pending-home-sales-rise

Nasdaq Jumps 150 Points; US Pending Home S...
09/29/2025 14:11:58

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market ...

12 Health Care Stocks Moving In Monday's P...
09/29/2025 12:09:33

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

IO Biotech Plans To Design New Registratio...
09/29/2025 11:16:40

FDA recommends that IO Biotech not submit a Biologics License Application (BLA) based on the data from the IOB-013 clinical tri...

IO Biotech Issues Update On Regulatory Pat...
09/29/2025 11:15:34

FDA recommends that IO Biotech not submit a Biologics License Application (BLA) based on the data from the IOB-013 clinical tri...

IO Biotech To Present Phase 3 And Final Ph...
09/23/2025 12:06:56

Oral presentation will highlight the results from the randomized Phase 3 trial (IOB-013/KN-D18) of IO102-IO103 cancer vaccine p...

12 Health Care Stocks Moving In Friday's I...
08/15/2025 17:07:19

IO Biotech Q2 EPS $(0.40) Misses $(0.35) E...
08/14/2025 20:35:37

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.35) ...

12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 17:07:02

Morgan Stanley Maintains Overweight on IO ...
08/12/2025 12:27:09

Morgan Stanley analyst Matthew Harrison maintains IO Biotech (NASDAQ:IOBT) with a Overweight and lowers the price target fro...